Surgical Science Sweden AB (publ) (STO:SUS)
143.90
-0.50 (-0.35%)
May 30, 2025, 5:29 PM CET
STO:SUS Revenue
Surgical Science Sweden AB had revenue of 250.69M SEK in the quarter ending March 31, 2025, with 33.17% growth. This brings the company's revenue in the last twelve months to 946.54M, up 12.41% year-over-year. In the year 2024, Surgical Science Sweden AB had annual revenue of 884.09M with 0.14% growth.
Revenue (ttm)
946.54M
Revenue Growth
+12.41%
P/S Ratio
7.76
Revenue / Employee
2.82M
Employees
274
Market Cap
7.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 884.09M | 1.23M | 0.14% |
Dec 31, 2023 | 882.85M | 80.31M | 10.01% |
Dec 31, 2022 | 802.54M | 435.76M | 118.81% |
Dec 31, 2021 | 366.78M | 261.98M | 249.98% |
Dec 31, 2020 | 104.80M | 3.28M | 3.23% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.30B |
Getinge AB | 35.57B |
Asker Healthcare Group AB | 15.57B |
Medicover AB | 23.56B |
Camurus AB | 2.04B |
AddLife AB | 10.42B |
Vimian Group AB | 4.24B |